This compound is primarily used in biochemical research to study glycosphingolipid metabolism. It acts as an inhibitor of glucosylceramide synthase, an enzyme involved in the synthesis of glycosphingolipids. By inhibiting this enzyme, it helps researchers understand the role of glycosphingolipids in cellular processes, particularly in the context of diseases like Gaucher's disease and other lysosomal storage disorders. Additionally, it is utilized in studies exploring the impact of glycosphingolipid modulation on cancer cell behavior and neurodegenerative diseases. Its application provides insights into potential therapeutic strategies targeting glycosphingolipid-related pathways.